Symbol | Mkt Cap | P/E | Current Ratio | Cash per Share | Operating Margin | EBIDTA Margin | Revenue Growth | Earnings Growth | H-Rank | C-Rank | h-rank |
---|---|---|---|---|---|---|---|---|---|---|---|
GILD | 91 B | 9.9 | 1.4 | 6.70 | 42 | 46 | -3.7 | -13 | 23 | 1 | 29 |
NVS | 197 B | 12 | 1.2 | 6.88 | 25 | 37 | 7.4 | 498 | 22 | 1 | 27 |
OGN | 4.6 B | 4.0 | 1.5 | 2.71 | 19 | 24 | 7.6 | 406 | 21 | 1 | 39 |
ABBV | 318 B | 14 | 0.87 | 7.25 | 31 | 48 | -5.4 | -66 | 26 | 2 | 35 |
AZN | 204 B | 12 | 0.82 | 3.78 | 16 | 32 | 7.3 | 5.9 | 25 | 2 | 43 |
BIIB | 32 B | 12 | 2.0 | 7.22 | 19 | 24 | -6.2 | -54 | 24 | 2 | 55 |
BMY | 105 B | 7.3 | 1.4 | 6.07 | 17 | 40 | 0.60 | -8.9 | 23 | 2 | 39 |
GRFS | 5.1 B | 4.9 | 2.8 | 0.95 | 12 | 15 | 3.3 | 178 | 20 | 2 | 31 |
GSK | 86 B | 9.3 | 0.89 | 1.40 | 20 | 35 | 9.2 | -76 | 24 | 2 | 53 |
JNJ | 376 B | 14 | 1.2 | 9.52 | 22 | 36 | 7.3 | 10 | 23 | 2 | 51 |
LLY | 734 B | 42 | 0.94 | 3.38 | 34 | 36 | 28 | 13 | 23 | 3 | 67 |
SNY | 120 B | 9.6 | 1.3 | 6.98 | 6.9 | 27 | 2.9 | 33 | 6 | 43 | |
MRK | 309 B | 12 | 1.3 | 2.80 | 0.08 | 13 | 5.8 | 36 | 8 | 63 | |
PFE | 156 B | 10.0 | 0.91 | 2.25 | -49 | 19 | -41 | 47 | 16 | 53 | |
MIRA | 18 M | -2.3 | 7.0 | 0.40 | 0.00 | 0.00 | 49 | 22 | 72 | ||
SCLX | 143 M | -4.0 | 0.19 | 0.04 | -136 | -216 | 12 | 68 | 41 | 64 | |
Q1=9.3 | Q3=1.4 | Q3=22.0 | Q3=36.0 | Q3=7.6 | Q3=178.0 | Q1=35.0 |
Total Records: 16. | Quotes | Help |
© George Elgin | Questions or Comments | Data last Modified 03/20/24 |